Patient selection
Renal denervation for hypertension
The Symplicity™ blood pressure procedure can help a wide range of patients you see in daily clinical practice.
Experts recommend renal denervation
A growing number of expert position and consensus statements from medical societies worldwide are shaping patient selection criteria for renal denervation, including the Symplicity blood pressure procedure.
The position is clear
A position paper from the European Society of Hypertension recommends renal denervation as an evidence-based treatment option for a wide range of patients.1
Growing consensus on renal denervation
Jose Garcia-Donaire, M.D., reviews global consensus statements that can help identify the right patients for renal denervation, including the Symplicity blood pressure procedure.
Select ideal patients for the Symplicity procedure
Patients who may be candidates for the Symplicity blood pressure procedure tend to fall into one of three groups. Typically, these patients are open to a balanced conversation about the procedure that takes their preferences into account.
Difficult to control
Patients who take multiple anti-hypertensive medications and are rigorously adherent — yet still not able to control their blood pressure (BP) — are often ready for a different treatment approach.2
Unwilling or unable to adhere
The more medications patients take, the lower their adherence.2-4 Non- adherence doubles when patients move from two to three pills.2-4 These factors may explain why nearly half of patients become non-adherent within one year.5
Motivated
Factors driving preference for the Symplicity blood pressure procedure tend to be associated with how clearly the patient understands the benefits of blood pressure reduction. These factors include:
- Personal experiences have made high blood pressure consequences real.2
- Perceive high blood pressure as a significant risk.2
- Blood pressure medication side effects have negatively impacted their lives.2
Renal denervation and uncontrolled hypertension
Professor Roland Schmieder, M.D., and Professor Tzung-Dau Wang, M.D., discuss patient selection, non-adherence, and the role of patient preference.
Insights on patient selection
Professor Isabella Sudano, PhD, discusses which patients are best suited for the Symplicity blood pressure procedure, including how to incorporate patient preference.
Explain the risks of HTN
Educate your patients about the risks of hypertension and why the Symplicity blood pressure procedure may be the right choice.
1
Schmieder R, Mahfoud F, Mancia G, et al. European Society of Hypertension position paper on renal denervation 2021. J Hypertens. 2021;39(9):1733-1741.
2
Schmieder R, Kandzari D, Wang TD, et. al. Differences in patient and physician perspectives on pharmaceutical therapy and renal denervation for the management of hypertension. J Hypertens. 2020. Doi:10.1097/HJH.0000000000002592.
3
Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). European Heart Journal. 2018;39(33):3021-3104. https://doi.org/10.1093/eurheartj/ehy339.
4
Schmieder RE, Mahfoud F, Azizi M, et al. European Society of Hypertension position paper on renal denervation 2018. J Hypertens. 2018;36(10):2042-2048.
5
Bruno RM, Taddei S, Borghi C, et al. Italian Society of Arterial Hypertension (SIIA) position paper on the role of renal denervation in the management of the difficult-to-treat hypertensive patient. High Blood Press Cardiovasc Prev. 2020;27:109-117.